Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Independently acquired biallelic JAK2 mutations are present in a minority of patients with essential thrombocythemia.

Literature DB >> 20705770

Independently acquired biallelic JAK2 mutations are present in a minority of patients with essential thrombocythemia.

Philip A Beer, Christina A Ortmann, Peter J Campbell, Anthony R Green.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2010 PMID： 20705770 PMCID： PMC3145103 DOI： 10.1182/blood-2010-05-284356

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

× No keyword cloud information.

6 in total

1. Microvariation artifacts introduced by PCR and cloning of closely related 16S rRNA gene sequences.

Authors: A G Speksnijder; G A Kowalchuk; S De Jong; E Kline; J R Stephen; H J Laanbroek
Journal: Appl Environ Microbiol Date: 2001-01 Impact factor: 4.792

Review 2. Guideline for investigation and management of adults and children presenting with a thrombocytosis.

Authors: Claire N Harrison; David Bareford; Nauman Butt; Peter Campbell; Eibhlean Conneally; Mark Drummond; Wendy Erber; Tamara Everington; Anthony R Green; Georgina W Hall; Beverley J Hunt; Christopher A Ludlam; Richard Murrin; Catherine Nelson-Piercy; Deepti H Radia; John T Reilly; Jon Van der Walt; Bridget Wilkins; Mary F McMullin
Journal: Br J Haematol Date: 2010-03-15 Impact factor: 6.998

3. Bias and artifacts in multitemplate polymerase chain reactions (PCR).

Authors: Takahiro Kanagawa
Journal: J Biosci Bioeng Date: 2003 Impact factor: 2.894

4. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

Authors: Damla Olcaydu; Ashot Harutyunyan; Roland Jäger; Tiina Berg; Bettina Gisslinger; Ingrid Pabinger; Heinz Gisslinger; Robert Kralovics
Journal: Nat Genet Date: 2009-03-15 Impact factor: 38.330

5. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.

Authors: Amy V Jones; Andrew Chase; Richard T Silver; David Oscier; Katerina Zoi; Y Lynn Wang; Holger Cario; Heike L Pahl; Andrew Collins; Andreas Reiter; Francis Grand; Nicholas C P Cross
Journal: Nat Genet Date: 2009-03-15 Impact factor: 38.330

6. In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm.

Authors: Jonathan R Lambert; Tamara Everington; David C Linch; Rosemary E Gale
Journal: Blood Date: 2009-06-18 Impact factor: 22.113

6 in total

3 in total